- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03001102
Preoperative Bath in Patients Submitted to Hip Arthroplasty
Preoperative Bath in Patients Submitted to Hip Arthroplasty: Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Despite the recommendation in several guidelines of preoperative bathing with 4% chlorhexidine gluconate as a measure for the prevention of SSI, there is no evidence in the literature that support this practice. The objective of this study is to evaluate the effect of nursing intervention: preoperative bath using 4% chlorhexidine gluconate solutions, 10% povidone iodine degermante or soap without antiseptic for the prevention of SSI in patients undergoing elective hip arthroplasty surgery. The specific objectives are to compare the incidence of SSI in the three interventions, to assess the most effective intervention for the prevention of surgical infection and to estimate the frequency of allergic reactions caused by the use of the solutions. Two intervention groups (4% Chlorhexidine gluconate and PVPI10%) and a control group (without antiseptic soap) composed of 52 patients undergoing hip arthroplasty in each group will be randomized to perform the baths in the period from may 2015 to june 2017. Before the intervention, nasal swabs will be collected of patients to investigate colonization by Staphylococcus aureus.
The expected result is lower ISC rate with the proposed measures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brazil
- Federal University of Minas Gerais
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Be 18 or older;
- Elective procedure of total hip arthroplasty
- No report of infectious focus at the surgical site
- Know to respond to the clinical signs of a surgical infection or having a person responsible with this ability
- Do not be a nasal carrier of Staphylococcus aureus before surgery
- Have access to fixed or mobile phone
Exclusion Criteria:
- Patient treating surgical site infection
- Emergency hip prosthesis surgery or orthopedic trauma
- Nasal carriers of Staphylococcus aureus before surgery
- Previous history of allergic reactions to the products used in the bat
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
SHAM_COMPARATOR: Bathing with 4% Chlorhexidine gluconate
Two baths with chlorhexidine using precise methods, including to scrubb the whole body with 50mL of undiluted solution, at night before surgery and the morning of surgery.
|
Cationic biguanide - antimicrobial action rubbing in the skin.
Other Names:
|
EXPERIMENTAL: Bathing with10% PVPI degermante
Two baths with PVPI using precise methods, including to scrubb the whole body with 50mL of undiluted solution for each bath, at night before surgery and the morning of surgery.
|
Polymer soluble in water of iodine with polyvinylpyrrolidone (PVP) - antimicrobial action rubbing in the skin.
Other Names:
|
ACTIVE_COMPARATOR: Bathing with soap without antiseptic.
Two baths with soap using precise methods, including to scrubb the whole body with 50mL of undiluted solution for each bath, at night before surgery and the morning of surgery.
|
Liquid soap with glycerin, neutral pH.
Skin cleansing
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infection of Surgical Site (SSI)
Time Frame: During the first 90 days after surgery
|
The infections that develop after the surgical procedure
|
During the first 90 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Allergic reactions
Time Frame: In the first hours after procedure
|
Adverse reaction to a given product
|
In the first hours after procedure
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Lúcia MC Franco, PhD student, Federal University of Minas Gerais
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Postoperative Complications
- Wounds and Injuries
- Surgical Wound
- Surgical Wound Infection
- Wound Infection
- Anti-Infective Agents
- Dermatologic Agents
- Disinfectants
- Plasma Substitutes
- Blood Substitutes
- Chlorhexidine
- Povidone-Iodine
- Povidone
- Chlorhexidine gluconate
- Anti-Infective Agents, Local
Other Study ID Numbers
- EE-UFMG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Wound Infection
-
St. Borbala HospitalSemmelweis University; Department of Surgery, Jahn Ferend Dél-Pesti Kórház... and other collaboratorsTerminatedSurgical Wound | Surgical Site Infection | Wound Dehiscence, Surgical | Dehiscence of Internal Surgical WoundHungary
-
Centro Hospitalar do Tâmega e SousaActive, not recruitingSurgical Wound | Surgical Wound Infection | Surgical Site Infection | Surgical Wound, Healed | Surgical Complication | Surgical Wound Dehiscence | Surgical Wound HaemorrhagePortugal
-
University of Nevada, Las VegasRecruitingColorectal Disorders | Surgical Site Infection | Wound SurgicalUnited States
-
HITEC-Institute of Medical SciencesCompletedWound Infection | Wound Dehiscence | Wound Surgical | Wound BleedingPakistan
-
Hull University Teaching Hospitals NHS TrustUniversity of HullRecruitingSurgical Wound | Wound Infection | Surgical Incision | Infection, Bacterial | Wound Infection, SurgicalUnited Kingdom
-
Next Science TMUniversity of Maryland, BaltimoreWithdrawnSurgical Wound | Surgical Wound Infection | Surgical Site Infection | Surgical Incision | Amputation Stump; Infection
-
Associazione Infermieristica per lo studio delle...Unknown
-
Clinique OrtosCompleted
-
Imperial College LondonWithdrawnSurgical Wound | Surgical Site Infection | Wound Infection | Surgical Incision
-
Rothman Institute OrthopaedicsUnknownSurgical IncisionUnited States
Clinical Trials on 4% Chlorhexidine gluconate
-
Medline IndustriesCompleted
-
Angela BiancoStryker NordicTerminatedCesarean Section | Surgical Site Infection | Nosocomial InfectionUnited States
-
Boston UniversityBill and Melinda Gates Foundation; Ministry of Health, Zambia; Zambia Center...Completed
-
Yaneve FongeRecruitingSurgical Site Infection | Cesarean Section; InfectionUnited States
-
University Of PerugiaFondazione Toscana Gabriele MonasterioCompleted
-
Columbia UniversityOrthopaedic Scientific Research Foundation IncCompletedInfection | Spinal InjuriesUnited States
-
University of MilanCompleted
-
Medline IndustriesCompleted
-
Aga Khan UniversityJohn Snow, Inc.Completed
-
Universidad de GuanajuatoUnknownVentilator Associated Pneumonia | ChlorhexidineMexico